Welcome to the summer edition of the Class Action & MDL Roundup, covering significant decisions and settlements from the second quarter of 2021.
In this edition, plaintiffs are doing their own science (badly), SCOTUS exposes a comma chameleon in the TCPA, and 400 cases are wiped out with one motion. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
We wrap up the Roundup with a summary of class action settlements finalized in the second quarter.
Class Action & MDL Roundup
Summer 2021
Class Action & MDL Roundup – Summer 2021
-
Cari K. Dawson
-
David Venderbush
-
Ryan P. Ethridge
-
Alexander Akerman
-
Gina Angiolillo
-
Charlotte M. Bohn
-
David Carpenter
-
F. Nicholas Chandler
-
Sean R. Crain
-
R. Blake Crohan
-
Jamie S. George
-
Bradley Harder
-
Kara F. Kennedy
-
Matthew D. Lawson
-
Andrew J. Liebler
-
Melissa Quintana
-
William J. Repko III
-
Jason Rottner
-
Troy A. Stram
-
Andrew T. Sumner
-
Amanda M. Waide
Meet the Authors
Senior Associate
Phone:
+1 404 881 7969
Other Phone:
+1 212 905 9156
Email:
nick.chandler@alston.com
Related News & Insights
-
Class Action & MDL Roundup June 24, 2025Class Action & MDL Roundup | 2025 Q1 – Our terms define classIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2025, two UK actions fail to clear a low bar, a movie isn’t a video, and spam isn’t free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup March 26, 2025Class Action & MDL Roundup | 2024 Q4 – We give you the benefit of the bargainIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the fourth quarter of 2024, an overdue audiobook suit is shelved, an old case gets new reps and new evidence, and face-swappers get SLAPPed. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup October 2, 2024Class Action & MDL Roundup 2024 Q2 – We are administratively feasibleIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the second quarter of 2024, there can be only one claim form for many, broiler chickens are coming home to roost, and there is no conspiracy of memes. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup July 2, 2024Class Action & MDL Roundup 2024 Q1 – Reaching across the pondIn the latest edition of the Class Action & MDL Roundup, covering notable class actions from the first quarter of 2024, UK High Court weighs in on information asymmetry, debit is better than credit, and it helps to have a credible plaintiff. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
-
Class Action & MDL Roundup December 18, 2023Class Action & MDL Roundup 2023 Q3 - Catching the class action waive(r)In the latest edition of the Class Action & MDL Roundup, covering notable class actions from the third quarter of 2023, a mistake is just a mistake, “99.99%” isn’t 100% clear, and faxes aren’t always free. Plus, we have our usual coverage of lawsuits over drugs and pharmaceuticals, wage-and-hour rules, shareholder losses, and more.
Media Contact